Calleris Giorgio, Marra Giancarlo, Corcione Silvia, Oderda Marco, Cardellino Chiara, Audagnotto Sabrina, Frea Bruno, De Rosa Francesco Giuseppe, Gontero Paolo
University of Turin, AOU "Città della Salute e della Scienza di Torino", Department of Surgical Sciences, Urology, Turin, Italy.
University of Turin, AO "Amedeo di Savoia", Department of Medical Sciences, Infectious Diseases, Turin, Italy.
Infez Med. 2017 Dec 1;25(4):366-370.
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy decreases the progression risk of non-muscle-invasive bladder cancer, but potentially yields a broad spectrum of side effects. We report the case of a 73-year-old man affected by miliary pulmonary BCG infection, whose microbiological diagnosis was probably hindered by empiric fluoroquinolones, focusing on imaging and clinical work-up.
膀胱内卡介苗(BCG)免疫疗法可降低非肌层浸润性膀胱癌的进展风险,但可能会产生广泛的副作用。我们报告了一例73岁男性粟粒性肺卡介苗感染病例,其微生物学诊断可能因经验性使用氟喹诺酮类药物而受到阻碍,本文重点关注影像学和临床检查。